logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12252547 B1

PDFFull Text
Date of Patent:
Mar. 18, 2025

Filed:

May. 11, 2021

Affinity entities comprising a tcr-like antibody binding domain with high affinity and fine specificity and uses of same

Applicant:

Adicet Therapeutics, Inc., Redwood City, CA (US);

Inventors:

Mira Peled Kamar, Herzlia, IL;

Galit Denkberg, Nofit, IL;

Yoram Reiter, Haifa, IL;

Ilan Beer, Haifa, IL;

Keren Sinik, Ramat-Yishai, IL;

Yael Teboul (Elbaz), Haifa, IL;

Yael Shperber (Sery), Kfar-Vradim, IL;

Reut Erel Segal, Haifa, IL;

Ravit Oren, Haifa, IL;

Dror Shmuel Alishekevitz, Kiryat-Tivon, IL;

Assignee:

ADICET THERAPEUTICS, INC., Redwood City, CA (US);

Attorney:

Todd Lorenz

Primary Examiner:

Brad Duffy

Int. Cl.
CPC ...
C07K 16/30 (2006.01); A61P 35/00 (2006.01); C07K 16/28 (2006.01); C07K 16/40 (2006.01); G01N 33/574 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/3053 (2013.01); A61P 35/00 (2018.01); C07K 16/2809 (2013.01); C07K 16/2833 (2013.01); C07K 16/30 (2013.01); C07K 16/40 (2013.01); G01N 33/5743 (2013.01); A61K 2039/505 (2013.01); C07K 2317/21 (2013.01); C07K 2317/31 (2013.01); C07K 2317/32 (2013.01); C07K 2317/34 (2013.01); C07K 2317/55 (2013.01); C07K 2317/622 (2013.01); C07K 2317/73 (2013.01); C07K 2317/92 (2013.01); C07K 2319/00 (2013.01); G01N 33/57492 (2013.01);
Abstract

Affinity binding entities having TCRL binding domain and methods of their use are provided. More specifically these compositions bind HLA-A2/WT1+, HLA-A2/MAGE-A4, HLA-A2/MAGE-A9, HLA-A2/PAP or HLA-A2/TyrD+ cells and as such can be used in diagnostics and therapy.

Find Patent Forward Citations

Peled Kamar, Mira. (2025). Affinity entities comprising a tcr-like antibody binding domain with high affinity and fine specificity and uses of same (U.S. Patent No. 12252547). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12252547

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…